1. Adelaide Research & Scholarship

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 40 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Immune selection during chronic hepadnavirus infectionMason, W.; Litwin, S.; Jilbert, A.
2005Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infectionMason, W.; Jilbert, A.; Summers, J.
2006Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infectionMiller, D.; Halpern, M.; Kotlarski, I.; Jilbert, A.
2004Molecular characterization of duck hepatitis B virus isolates from South African ducksMangisa, N.; Smuts, H.; Kramvis, A.; Linley, C.; Skelton, M.; Tucker, T.; de la M Hall, P.; Kahn, D.; Jilbert, A.; Kew, M.
2010The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccinesFeng, F.; Teoh, C.; Qiao, Q.; Boyle, D.; Jilbert, A.
2007The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphologyXu, C.; Yamamoto, T.; Zhou, T.; Aldrich, C.; Frank, K.; Cullen, J.; Jilbert, A.; Mason, W.
2008Antiviral therapy with entecavir combined with post-exposure “prime-boost” vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infectionMiller, D.; Boyle, D.; Feng, F.; Reaiche-Miller, G.; Kotlarski, I.; Colonno, R.; Jilbert, A.
2010The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesisReaiche-Miller, G.; Le Mire, M.; Mason, W.; Jilbert, A.
2006DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent mannerMiller, D.; Kotlarski, I.; Jilbert, A.
2008Preclinical development of the amphipathic DNA polymer REP 9AC for the treatment of hepatitis B virus InfectionNoordeen, F.; Vaillant, A.; Juteau, J.; Jilbert, A.

Discover